GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » FCF Yield %

Acticor Biotech (XPAR:ALACT) FCF Yield % : -94.44 (As of May. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Acticor Biotech's Trailing 12-Month Free Cash Flow is €-13.78 Mil, and Market Cap is €14.59 Mil. Therefore, Acticor Biotech's FCF Yield % for today is -94.44%.

The historical rank and industry rank for Acticor Biotech's FCF Yield % or its related term are showing as below:

XPAR:ALACT' s FCF Yield % Range Over the Past 10 Years
Min: -325.3   Med: 0   Max: 0
Current: -94.44


XPAR:ALACT's FCF Yield % is ranked worse than
83.88% of 1557 companies
in the Biotechnology industry
Industry Median: -14.1 vs XPAR:ALACT: -94.44

Acticor Biotech's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.


Acticor Biotech FCF Yield % Historical Data

The historical data trend for Acticor Biotech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech FCF Yield % Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Yield %
Get a 7-Day Free Trial - - - -28.66 -16.32

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
FCF Yield % Get a 7-Day Free Trial Premium Member Only - -33.73 -17.31 -15.66 -24.45

Competitive Comparison of Acticor Biotech's FCF Yield %

For the Biotechnology subindustry, Acticor Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acticor Biotech's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acticor Biotech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Acticor Biotech's FCF Yield % falls into.



Acticor Biotech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Acticor Biotech's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-12.11 / 74.21472
=-16.32%

Acticor Biotech's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-7.966 * 2 / 65.16562
=-24.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acticor Biotech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Acticor Biotech FCF Yield % Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Acticor Biotech (XPAR:ALACT) Business Description

Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines